Aerovate Therapeutics Inc

-

Stock Issuer and Owners

Home | Sign Up | Log In
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
Latest Filings
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Aerovate Therapeutics Inc
TickerAVTE
CIK #0001798749
CUSIP008064107
SectorLife Sciences - Pharmaceutical Preparations
Address200 Berkeley Street Floor 18, Boston, MA 02116
Source [EDGAR]
CIK Filing 2011 - 2024
[0001798749] 10-K
[0001798749] 10-Q
[0001798749] 3
[0001798749] 4
[0001798749] 8-K
[0001798749] D
[0001798749] SC 13D
[0001798749] SC 13G
Form 13D/13G Filer Form 13D/13G Subject Filed % Owned
Baker Bros Advisors LP Aerovate Therapeutics Inc [2022-02-14] 7.5
Atlas Venture Associates XII LLC Aerovate Therapeutics Inc [2021-11-05] 12.7
Sofinnova Venture Partners X LP Aerovate Therapeutics Inc [2021-07-13] 11.0
Citadel Advisors LLC Aerovate Therapeutics Inc [2021-07-12] 6.6
Cormorant Asset Management LP Aerovate Therapeutics Inc [2021-07-12] 3.36
RA Capital Management LP Aerovate Therapeutics Inc [2021-07-12] 33.9
Form 3/4/5 Filer 2011 - 2024
Aerovate Therapeutics, Inc.
Santel Donald J
Katabi Maha
RA Capital Healthcare Fund LP
RA Capital Nexus Fund, L.P.
RA Capital Management LP
Shah Rajeev M.
Kolchinsky Peter
Dake Benjamin T
Dorval Allison
Iwicki Mark T
Resnick Joshua
Grayzel David S
Niven Ralph
Gillies Hunter
Verwijs Marinus
Noyes Timothy P
Pigot Timothy
Eldridge George A
Atlas Venture Fund XII, L.P.
Chen Bihua
Cormorant Global Healthcare Master Fund, LP
Cormorant Asset Management, LP
Cormorant Private Healthcare Fund II, LP
Atlas Venture Associates XII, L.P.
Atlas Venture Associates XII, LLC
Sofinnova Management X, L.P.
Sofinnova Venture Partners X, L.P.
Healy James
Form 13F Holdings
Firm Period DFND Voting Shares
RA Capital Management LP [2023-03-31] SOLE 0.0 8,263,982.0
Sofinnova Investments Inc [2023-03-31] SOLE 3,758,686.0 3,758,686.0
Atlas Venture Life Science Advisors LLC [2023-03-31] SOLE 2,039,249.0 2,039,249.0
Baker Bros Advisors LP [2023-03-31] SOLE 1,963,479.0 1,963,479.0
Cormorant Asset Management LP [2023-03-31] DFND 1,561,696.0 1,561,696.0
TCG Crossover Management LLC [2023-03-31] SOLE 1,081,274.0 1,081,274.0
VR Adviser LLC [2023-03-31] SOLE 833,927.0 833,927.0
OrbiMed Advisors LLC [2023-03-31] DFND 215,100.0 756,930.0
Great Point Partners LLC [2023-03-31] DFND 0.0 755,620.0
Octagon Capital Advisors LP [2023-03-31] SOLE 621,712.0 621,712.0
OUP Management Co LLC [2023-03-31] SOLE 603,762.0 603,762.0
BlackRock Inc. [2023-03-31] SOLE 587,175.0 599,999.0
FMR LLC [2023-03-31] DFND 570,180.0 570,965.0
Vanguard Group Inc [2023-03-31] SOLE 0.0 498,357.0
Frazier Life Sciences Management LP [2023-03-31] SOLE 338,110.0 338,110.0
Ghost Tree Capital LLC [2023-03-31] SOLE 200,000.0 200,000.0
Ikarian Capital LLC [2023-03-31] SOLE 195,146.0 195,146.0
Geode Capital Management LLC [2023-03-31] DFND 187,499.0 187,499.0
State Street Corp [2023-03-31] DFND 172,993.0 184,593.0
Fred Alger Management LLC [2023-03-31] SOLE 104,048.0 104,048.0
Nantahala Capital Management LLC [2023-03-31] SOLE 95,000.0 95,000.0
Northern Trust Corp [2023-03-31] DFND 798.0 77,439.0
Point72 Asset Management LP [2023-03-31] DFND 0.0 69,119.0
Skandinaviska Enskilda Banken AB (publ) [2023-03-31] DFND 0.0 50,866.0
Eversept Partners LP [2023-03-31] SOLE 50,242.0 50,242.0
Nan Fung Group Holdings Ltd [2023-03-31] DFND 47,936.0 47,936.0
Morgan Stanley [2023-03-31] DFND 44,794.0 44,974.0
Boothbay Fund Management LLC [2023-03-31] OTR 0.0 39,573.0
Nuveen Asset Management LLC [2023-03-31] DFND 36,310.0 36,310.0
Bank of New York Mellon Corp [2023-03-31] DFND 23,876.0 27,795.0
Prev | Page 1 | Next
Terms | Privacy | Guide
tony@aum13f.com